Cefuroxime Dosing in Renal Transplant Patients with Stable Graft Function
For renal transplant patients with stable graft function, dose cefuroxime based on creatinine clearance using the FDA-approved renal dosing table: 750 mg-1.5 grams every 8 hours for CrCl >20 mL/min, 750 mg every 12 hours for CrCl 10-20 mL/min, and 750 mg every 24 hours for CrCl <10 mL/min 1.
Dosing Algorithm by Creatinine Clearance
The FDA label provides explicit guidance for renal impairment that applies to transplant patients with stable graft function:
- CrCl >20 mL/min: Standard dosing of 750 mg to 1.5 grams every 8 hours
- CrCl 10-20 mL/min: 750 mg every 12 hours
- CrCl <10 mL/min: 750 mg every 24 hours
- Hemodialysis patients: Give an additional dose after dialysis 1
The specific dose within the range (750 mg vs 1.5 grams) depends on infection severity—use 750 mg for uncomplicated infections (UTI, skin/soft tissue, uncomplicated pneumonia) and 1.5 grams for severe or complicated infections 1.
Calculating Creatinine Clearance
When only serum creatinine is available, use the Cockcroft-Gault formula provided in the FDA label 1:
Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
Females: 0.85 × male value
The serum creatinine must represent steady-state renal function, which is a critical consideration in transplant patients.
Special Considerations for Transplant Patients
Assessing Stable Graft Function
In the immediate post-transplant period (first 1-3 days), standard creatinine clearance formulas are unreliable because serum creatinine has not reached steady state 2. Only use these dosing recommendations once graft function has stabilized, typically 3+ days post-transplant when creatinine values are stable.
Pharmacokinetic Evidence
Research confirms that cefuroxime clearance correlates linearly with creatinine clearance 3, 4, 5. The elimination half-life increases dramatically with declining renal function: from 1.4 hours with normal function to 16.8 hours when CrCl <15 mL/min 3. Approximately 89% of cefuroxime is renally excreted 1, making dose adjustment essential in renal impairment.
Augmented Renal Clearance
Be aware that some transplant patients may have augmented renal clearance (CrCl >150 mL/min) after successful transplantation. While this is less common with stable grafts, if present, standard dosing remains appropriate as the FDA table covers CrCl >20 mL/min without upper limits 1.
Duration and Monitoring
Continue therapy for a minimum of 48-72 hours after the patient becomes asymptomatic or after bacterial eradication is documented 1. For streptococcal infections, treat for at least 10 days to prevent rheumatic fever or glomerulonephritis 1.
Common Pitfalls to Avoid
- Do not use standard formulas in the immediate post-transplant period when creatinine is changing daily—wait for stabilization
- Do not underdose in moderate renal impairment (CrCl 20-50 mL/min)—these patients still receive every 8-hour dosing
- Remember the post-dialysis dose in patients requiring hemodialysis, as cefuroxime is dialyzable 1
- Ensure steady-state creatinine before calculating clearance, as fluctuating values will give inaccurate estimates